Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-08-17 to 2023-09-07
Current total value of award: $267.62
Description: 8510085666!HEPATITIS B VIRUS V